Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Twist Bioscience Corporat...

    NASDAQ: TWST · Real-Time Price · USD
    28.23
    0.07 (0.25%)
    At close: May 23, 2025, 3:59 PM
    28.01
    -0.78%
    After-hours: May 23, 2025, 05:56 PM EDT
    0.25%
    Bid 27.66
    Market Cap 1.69B
    Revenue (ttm) 347.68M
    Net Income (ttm) -191.15M
    EPS (ttm) -3.25
    PE Ratio (ttm) -8.69
    Forward PE -20.97
    Analyst Buy
    Ask 28.94
    Volume 590,543
    Avg. Volume (20D) 1,229,076
    Open 27.34
    Previous Close 28.16
    Day's Range 27.12 - 28.44
    52-Week Range 27.12 - 60.90
    Beta 2.54

    About TWST

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol TWST
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for TWST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    2 weeks ago
    -8.44%
    Twist Bioscience shares are trading lower after th... Unlock content with Pro Subscription
    5 months ago
    +9.87%
    Twist Bioscience shares are trading higher after Leerink Partners maintained its Hold rating on the stock.
    news image

    1 day ago · businesswire.com

    Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

    SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care se...

    news image

    1 week ago · businesswire.com

    Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    1 week ago · businesswire.com

    Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (“Twist” or the “Company”), a core mid-cap growth and val...

    news image

    2 weeks ago · businesswire.com

    Twist Bioscience and Ginkgo Bioworks Revise Collaboration

    SOUTH SAN FRANCISCO, Calif. & BOSTON--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care secto...

    news image

    2 weeks ago · seekingalpha.com

    Twist Bioscience: Expansion Efforts Continue To Face Challenges

    Twist Bioscience reported solid results in Q2, but management's downbeat tone on the earnings call suggest there are challenges ahead. Twist has also spun-out its data storage business, which will hel...

    news image

    2 weeks ago · seekingalpha.com

    Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

    Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2025 Earnings Conference Call April 5, 2025 8:00 AM ET Company Participants Angela Bitting - Senior Vice President of Corporate Affairs Emily Leproust - ...

    news image

    2 weeks ago · zacks.com

    Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates

    Twist Bioscience (TWST) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.56. This compares to loss of $0.79 per share a year ago.

    news image

    2 weeks ago · businesswire.com

    Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    2 weeks ago · businesswire.com

    Twist Bioscience Spins Out DNA Data Storage as Independent Company

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today ...

    news image

    3 weeks ago · seekingalpha.com

    Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

    Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, Twis...

    Add to Watchlist